Movement Alert|Guardant Health Inc. falls 5.69% in Pre-Market Trading, convertible note overhang remains in focus

Market Focus11-20 22:09

On November 20, Guardant Health Inc. falls 5.69% in Pre-Market Trading, trading at $143.07/share, with turnover of $373,200.

The clearest catalyst in recent public information is continued investor focus on the company’s recently priced and settled $500 million zero-coupon convertible senior notes due 2032, with the market weighing potential future conversion dilution and financing overhang.

Company disclosures showed expected net proceeds of about $538.3 million if the full option is exercised. Guardant Health Inc. said about $501.7 million would be used to repurchase roughly $395.2 million principal amount of its 2027 zero-coupon convertible notes, while the remaining proceeds, together with cash on hand, would fund about $51.7 million of capped call transactions intended to offset future dilution and extend debt maturities.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment